Janux Therapeutics, Inc. (JANX)

SEC filing

Janux Therapeutics, Inc.

JANX · CIK 1817713

4 · Oct 30, 2025 · Meyer Andrew Hollman sold 16.66K shares at $30.06/share ($501.0K); exercised options for 16.66K shares

Meyer Andrew Hollman sold 16.66K shares at $30.06/share ($501.0K); exercised options for 16.66K shares

xslF345X05/form4-10302025_081001.xml

xslF345X05/form4-10302025_081001.xmlSEC.gov

Graphics and non-inline formats (not embedded below).